In addition, including data of patients of other races such as from Southeast Asian, Mediterranean and Arctic populations would add confidence and accuracy to the conclusions of MACC1’s potential as a NPC prognostic biomarker. This evidence concerns the gene MACC1 and nasopharyngeal carcinoma.